![Pieter B. M. W. M. Timmermans](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Pieter B. M. W. M. Timmermans
Directeur Technique/Scientifique/R&D chez Kosan Biosciences, Inc.
Postes actifs de Pieter B. M. W. M. Timmermans
Sociétés | Poste | Début | Fin |
---|---|---|---|
Kosan Biosciences, Inc.
![]() Kosan Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Kosan Biosciences, Inc. develops drugs for cancer therapeutics. The company was founded in 1995 and is headquartered in New York, NY. | Directeur Technique/Scientifique/R&D | 01/01/2005 | - |
Historique de carrière de Pieter B. M. W. M. Timmermans
Anciens postes connus de Pieter B. M. W. M. Timmermans
Sociétés | Poste | Début | Fin |
---|---|---|---|
AMGEN INC. | Corporate Officer/Principal | 01/08/2004 | 01/01/2005 |
Tularik, Inc.
![]() Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01/01/1997 | 01/01/2004 |
University of Amsterdam | Corporate Officer/Principal | - | - |
Formation de Pieter B. M. W. M. Timmermans
University of Leiden | Doctorate Degree |
Statistiques
Internationale
Etats-Unis | 4 |
Pays-Bas | 3 |
Opérationnelle
Corporate Officer/Principal | 3 |
Chief Tech/Sci/R&D Officer | 1 |
Doctorate Degree | 1 |
Sectorielle
Health Technology | 3 |
Consumer Services | 3 |
Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
AMGEN INC. | Health Technology |
Entreprise privées | 2 |
---|---|
Kosan Biosciences, Inc.
![]() Kosan Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Kosan Biosciences, Inc. develops drugs for cancer therapeutics. The company was founded in 1995 and is headquartered in New York, NY. | Health Technology |
Tularik, Inc.
![]() Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | Commercial Services |